AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
| Tag | Subject | ||||||
|---|---|---|---|---|---|---|---|
| MET | Ann: Orion Point Site Unconditional | 17/04/18 | 0 | 30 | |||
|
|||||||
| MET | Ann: D&O Ongoing Disclosure - Alistair Ryan | 05/04/18 | 0 | 26 | |||
|
|||||||
| MET | Ann: ASX Appendix 3A.1 | 29/03/18 | 0 | 26 | |||
|
|||||||
| MET | Ann: D&O Ongoing Disclosure - Roderick Snodgrass | 08/03/18 | 0 | 40 | |||
|
|||||||
| MET | Ann: 2018 Interim Report | 06/03/18 | 0 | 31 | |||
|
|||||||
| MET | Ann: ASX Appendix 3A.1 (Cross-filed) | 26/02/18 | 0 | 39 | |||
|
|||||||
| MET | Ann: Half Year Result | 26/02/18 | 0 | 22 | |||
|
|||||||
See All Discussions
NZX News